The YTD Canine and Feline core vaccine purchasing indices were down slightly (-0.3%) at +15.4% across the 32,000+ practices and shelter locations
For the week ending September 4, 2021, year over year growth remained robust though continues to slow versus the previous year with each of the respective categories moving between (-0.4%) and (-0.1%) versus the previous week’s YTD results.
For the week ending Aug 28, 2021, year over year growth remained robust but continues to slow versus the previous year with each of the respective categories moving between (-0.3%) and +0.9% versus the previous week’s YTD results.
For the week ending Aug 21, 2021, year over year growth remained robust but continues to slow versus the previous year with each of the respective categories moving between (-0.4%) and +0.5% versus the previous week’s YTD results.
The YTD Canine and Feline core vaccine purchasing indices were down slightly (-0.3%) at +16.6% across the 32,000+ practices and shelter locations in the Animalytix Marketplace.
Revenue growth for the week dropped (-0.1%) nationally compared to the previous week, falling to +11.3% growth YTD for the ~4,000 reporting practices.
For the week ending July 31, 2021, year over year growth remained robust but continues to slow versus the previous year with each of the respective categories moving downward between 0.1% - 0.5% versus the previous week’s YTD results. The YTD Canine and Feline core vaccine purchasing indices were down (-0.2%) at +17.3% across the 32,000+ practices and shelter locations in the Animalytix Marketplace.
For the week ending July 24, 2021, aggregate YTD practice revenues held relatively steady at +11.7% net growth versus YTD 2020 for the ~4,000 reporting practices.
For the week ending July 17, 2021, the Canine and Feline core vaccine indices continue to moderate versus previous weeks as YTD growth moved downward plateauing at +18.1% across the 32,000+ practices and shelter locations in the Animalytix Marketplace.
Purchases of Surgical Suite consumables which serve as a proxy for incidence of surgical procedures are softer but robust at +16.4% growth YTD.
For the week ending July 3, 2021, the Canine and Feline core vaccine indices continue to moderate versus previous weeks as YTD growth moved downward slightly to +19.5% across the 32,000+ practices and shelter locations in the Animalytix Marketplace.
Revenue growth for the week fell back (-0.3%) points compared to last week nationally but further plateaued and softened to +12.6% growth YTD for the ~4,000 reporting practices.
For the week ending June 19, 2021, the Canine and Feline core vaccine indices continue to moderate versus previous weeks as YTD growth declined to a still robust +22.5% across the 32,000+ practices and shelter locations in the Animalytix Marketplace.
For the week ending June 12, 2021, the Canine and Feline core vaccine indices continue to moderate versus previous weeks as YTD growth declined to a still robust +23.9% across the 32,000+ practices and shelter locations in the Animalytix Marketplace.
For the week ending June 5, 2021, the Canine and Feline core vaccine indices continue to moderate versus previous weeks as YTD growth declined to a still robust +26.1% across the 32,000+ practices and shelter locations in the Animalytix Marketplace.
For the week ending May 29, 2021, the Canine and Feline core vaccine indices continue to moderate versus previous weeks as YTD growth continues to plateau at +28.8% across the 32,000+ practices and shelter locations in the Animalytix Marketplace.
For the week ending May 22, 2021, the Canine and Feline core vaccine indices continue to moderate versus previous weeks as YTD growth continues to plateau at +29.5% across the 32,000+ practices and shelter locations in the Animalytix Marketplace.
For the week ending May 15, 2021, the Canine and Feline core vaccine indices continue to moderate versus previous weeks as YTD growth continues to plateau at +30.1% across the 32,000+ practices and shelter locations in the Animalytix Marketplace.
For the week ending May 8, 2021, the Canine and Feline core vaccine indices were tempered a bit compared to previous weeks as YTD growth has now plateaued at +31.2% across the 32,000+ practices and shelter locations in the Animalytix Marketplace.
For the week ending May 1, 2021, the Canine and Feline core vaccine indices combined and expanded with the inclusion of the “Lifestyle” vaccines for Lyme, Lepto, and FeLV, remain up at a very robust +30.6% YTD across the 32,000+ practices and shelter locations in the Animalytix Marketplace.
For the week ending April 24, 2021, aggregate YTD practice revenues improved versus the previous week, posting a very robust net growth of +15.4% for the ~4,000 reporting practices.
For the week ending April 17, 2021, the Canine and Feline core vaccine indices combined and expanded with the inclusion of the “Lifestyle” vaccines for Lyme, Lepto, and FeLV, shot up to a very robust +29.3% YTD across the 32,000+ practices and shelter locations in the Animalytix Marketplace.
For the week ending April 10, 2021, the Canine and Feline core vaccine indices combined and expanded with the inclusion of the “Lifestyle” vaccines for Lyme, Lepto, and FeLV, improved to a very robust +27.0% YTD across the 32,000+ practices and shelter locations in the Animalytix Marketplace.
For the week ending April 3, 2021, the Canine and Feline core vaccine indices combined and expanded with the inclusion of the “Lifestyle” vaccines for Lyme, Lepto, and FeLV, improved to a very robust +23.7% YTD across the 32,000+ practices and shelter locations in the Animalytix Marketplace.
For the week ending March 27, 2021, the canine and feline core vaccine indices combined and expanded with the inclusion of the “Lifestyle” vaccines for Lyme, Lepto, and FeLV, ended at a very robust 16.7% YTD growth across the 32,000+ practices and shelter locations in the Animalytix Marketplace.
For the week ending March 20, 2021, the canine and feline core vaccine indices combined and expanded with the inclusion of the “Lifestyle” vaccines for Lyme, Lepto, and FeLV, ended at a robust 11.2% YTD growth across the 32,000+ practices and shelter locations in the Animalytix Marketplace
For the week ending March 13, 2021, the canine and feline core vaccine indices combined and expanded with the inclusion of the “Lifestyle” vaccines for Lyme, Lepto, and FeLV, remained at a very robust +11.0% YTD across the 32,000+ practices and shelter locations in the Animalytix Marketplace.
This week’s totals for reported parasiticide purchases across all segments year to date through the week ending March 6, are ahead of 2020 results by an extremely robust +12.2% among the 32,000+ practices and shelter locations in the Animalytix Marketplace.
• Core & Lifestyle Canine & Feline Vaccine practice purchasing remain at a robust positive year to date value, breaking +11.3% nationally. Annual core and lifestyle vaccine purchases were selected as the principal metric given 50% or more of annual visits to a veterinary practice are associated with the administration of these products.
For the week ending February 13, 2021, the canine and feline core vaccine indices combined and expanded with the inclusion of the “Lifestyle” vaccines for Lyme, Lepto, and FeLV, ended up at a very robust +13.7% YTD across the 32,000+ practices and shelter locations in the Animalytix Marketplace.
For the week ending February 6, 2021, the canine and feline core vaccine indices combined and expanded with the inclusion of the “Lifestyle” vaccines for Lyme, Lepto, and FeLV, ended at a robust 11.5% YTD growth across the 32,000+ practices and shelter locations in the Animalytix Marketplace.
For the final 2020 week 52 ending January 2, 2021, aggregate YTD practice revenues improved from 5.0% the previous month to 5.6% growth for the ~4,000 reporting practices.
For the week ending December 12th, aggregate YTD practice revenues improved from 5.2% the previous week to 5.4% growth for the ~4,000 reporting practices.
For the week ending December 5th, aggregate YTD practice revenues improved from 5.0% last week to 5.2% growth for the ~4,000 reporting practices. Unique patients and clients continue to improve as well and for the first-time total invoices moved into positive territory at 0.1% YTD compared to 2019.
For the week ending November 28th, the canine and feline core vaccine indices combined and expanded with the inclusion of the “Lifestyle” vaccines for Lyme, Lepto, and FeLV, is currently running at a robust 8.5% YTD growth
Week 46 of 2020 ending November 21st for VetWatch we observed fairly robust growth in the canine and feline core and lifestyle vaccines with a 8.2% increase over the same time period in 2019 across the 32,000+ practices and shelter locations in the Animalytix Marketplace.
YTD totals for reported parasiticide purchases for the week ending November 14th, remain ahead of 2019 results by 7.5% which reflects a very robust weekly result, driving YTD totals upwards by a full 1% versus last week.
For the week ending November 7th, the canine and feline core vaccine indices combined and expanded with the inclusion of the “Lifestyle” vaccines for Lyme, Lepto, and FeLV is currently running at a 7.1% YTD growth across the 32,000+ practices and shelter locations in the Animalytix Marketplace.
For the week ending October 31, aggregate YTD practice revenues improved from 3.9% last week to 4.7% growth for the ~4,000 reporting practices.
The canine and feline core vaccine indices have now been combined and expanded with the inclusion of the “Lifestyle” vaccines for Lyme, Lepto, and FeLV. This index is currently running at a 6.5% YTD growth across the 32,000+ practices and shelter locations in the Animalytix Marketplace.
YTD totals for reported parasiticide sales for the week ending October 17, retreated slightly from the YTD results at 5.6% (vs the previous 8.5%) across the combined performance of 32,000+ practices and shelter locations in the Animalytix Marketplace.
For the week ending October 10, the YTD practice revenue improved with year to date growth of 4.0% for the ~4,000 reporting practices. Though total invoices continue to lag behind prior year to date, this week saw a very positive move to (-1.1%) YTD over 2019 bringing invoices closer to parity with last year.
For the week ending October 3, the YTD practice revenue improved with year to date growth of 3.9% for the ~4,000 reporting practices...
For the week ending September 26, the YTD practice revenue improved with year to date growth of 3.7% for the ~4,000 reporting practices.
YTD results for the week ending September 19, 2020, show all reported segments of veterinary sales continue to hold positive positions versus 2019 results...
For the week ending September 12, 2020, the US market for veterinary goods continues among the six categories reported in a positive YTD growth position...
The US market for veterinary goods for year to date ending Sept 5, 2020, marks the fourth consecutive week since the onset of the Covid-19 Pandemic in mid-March that all reporting categories were in positive YTD growth positions.
The US market for veterinary goods for year to date ending Aug 29, 2020, marks the third consecutive week since the onset of the Covid-19 Pandemic in mid-March that all reporting categories were in positive YTD growth positions...
The year to date ending Aug 22, 2020 for the US market for veterinary goods marks the second consecutive week since the onset of the Covid-19 Pandemic in mid-March that all reporting categories were in positive YTD growth positions. This week only feline core vaccines showed a slight deceleration in its growth trend year to date compared to last week...
